Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.585 AUD | 0.00% | +7.34% | +14.71% |
Apr. 16 | Euroz Hartleys Adjusts Argenica Therapeutics’ Price Target to AU$1.40 From AU$1.50, Keeps at Speculative Buy | MT |
Apr. 12 | Argenica Therapeutics Raises AU$12 Million via Placement | MT |
Sales 2022 | 0.26 0.4 | Sales 2023 | 1.75 2.67 | Capitalization | 36.88M 56.24M |
---|---|---|---|---|---|
Net income 2022 | -4M -6.1M | Net income 2023 | -4M -6.1M | EV / Sales 2022 | 109,850,751 x |
Net cash position 2022 | 8.91M 13.59M | Net cash position 2023 | 9.34M 14.24M | EV / Sales 2023 | 15,739,424 x |
P/E ratio 2022 |
-7.77
x | P/E ratio 2023 |
-6.82
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 88.43% |
1 week | +7.34% | ||
Current month | -12.69% | ||
1 month | -9.30% | ||
3 months | +3.54% | ||
6 months | +75.94% | ||
Current year | +14.71% |
Managers | Title | Age | Since |
---|---|---|---|
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Emma Waldon
DFI | Director of Finance/CFO | - | - |
Meghan Thomas
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry C. Budge
BRD | Director/Board Member | 72 | - |
Geoff Pocock
BRD | Director/Board Member | - | - |
Dianne Angus
BRD | Director/Board Member | 63 | Nov. 30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.585 | 0.00% | 100 301 |
24-05-01 | 0.585 | 0.00% | 213,687 |
24-04-30 | 0.585 | +8.33% | 498,591 |
24-04-29 | 0.54 | -4.42% | 353,268 |
24-04-26 | 0.565 | +0.89% | 119,835 |
Delayed Quote Australian S.E., May 02, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+14.71% | 46.67M | |
+25.36% | 42.68B | |
-2.97% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.45% | 24.94B | |
-20.22% | 18.96B | |
+28.85% | 12.3B | |
-2.98% | 11.95B | |
-1.44% | 11.55B |
- Stock Market
- Equities
- AGN Stock